GLP-1 analogs and DPP-4 inhibitors in type 2 diabetes therapy: review of head-to-head clinical trials
We dont yet have studies on the long-term effects of GLP-1 therapies in teens, so young patients taking them are practically participants in a research study. Whats more, Cooper and others say, GLP-1s are already being prescribed off label to children under age 12
Because Glucose Control is intended for type 2 diabetes management, it should be used under a doctor's supervision and never as a reason to stop prescribed medication
They may protect cartilage and reduce joint inflammation, lower the levels of inflammatory cytokines, and help prevent further joint damage and address both the metabolic and inflammatory aspects, reducing cytokine levels and potentially improving disease outcomes
If side effects persist or worsen, your healthcare provider can help adjust your treatment plan